nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Anagrelide—hematologic cancer	0.0738	0.101	CbGbCtD
Thiabendazole—CYP1A1—Methoxsalen—hematologic cancer	0.0738	0.101	CbGbCtD
Thiabendazole—CYP1A1—Bortezomib—hematologic cancer	0.0702	0.0965	CbGbCtD
Thiabendazole—CYP1A1—Daunorubicin—hematologic cancer	0.0672	0.0923	CbGbCtD
Thiabendazole—CYP1A1—Thalidomide—hematologic cancer	0.0612	0.0841	CbGbCtD
Thiabendazole—CYP1A1—Dacarbazine—hematologic cancer	0.0526	0.0723	CbGbCtD
Thiabendazole—CYP1A1—Dasatinib—hematologic cancer	0.0413	0.0568	CbGbCtD
Thiabendazole—CYP1A2—Carmustine—hematologic cancer	0.0388	0.0533	CbGbCtD
Thiabendazole—CYP1A2—Methoxsalen—hematologic cancer	0.033	0.0453	CbGbCtD
Thiabendazole—CYP1A2—Bortezomib—hematologic cancer	0.0314	0.0431	CbGbCtD
Thiabendazole—CYP1A2—Daunorubicin—hematologic cancer	0.03	0.0412	CbGbCtD
Thiabendazole—CYP1A2—Alitretinoin—hematologic cancer	0.0294	0.0404	CbGbCtD
Thiabendazole—CYP1A2—Thalidomide—hematologic cancer	0.0273	0.0376	CbGbCtD
Thiabendazole—CYP1A2—Dacarbazine—hematologic cancer	0.0235	0.0323	CbGbCtD
Thiabendazole—CYP1A2—Imatinib—hematologic cancer	0.023	0.0316	CbGbCtD
Thiabendazole—CYP1A1—Dexamethasone—hematologic cancer	0.0212	0.0291	CbGbCtD
Thiabendazole—CYP1A2—Dasatinib—hematologic cancer	0.0185	0.0254	CbGbCtD
Thiabendazole—CYP1A2—Etoposide—hematologic cancer	0.0115	0.0158	CbGbCtD
Thiabendazole—Lansoprazole—ATP4A—hematologic cancer	0.00324	0.693	CrCbGaD
Thiabendazole—Lansoprazole—ABCG2—hematologic cancer	0.00101	0.217	CrCbGaD
Thiabendazole—Lansoprazole—ABCB1—hematologic cancer	0.000422	0.0903	CrCbGaD
Thiabendazole—Headache—Thiotepa—hematologic cancer	9.98e-05	0.000419	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	9.97e-05	0.000419	CcSEcCtD
Thiabendazole—Decreased appetite—Etoposide—hematologic cancer	9.94e-05	0.000418	CcSEcCtD
Thiabendazole—Diarrhoea—Ifosfamide—hematologic cancer	9.91e-05	0.000417	CcSEcCtD
Thiabendazole—Nausea—Vinorelbine—hematologic cancer	9.9e-05	0.000416	CcSEcCtD
Thiabendazole—Asthenia—Mitoxantrone—hematologic cancer	9.87e-05	0.000415	CcSEcCtD
Thiabendazole—Asthenia—Irinotecan—hematologic cancer	9.87e-05	0.000415	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—hematologic cancer	9.86e-05	0.000415	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—hematologic cancer	9.8e-05	0.000412	CcSEcCtD
Thiabendazole—Vomiting—Thalidomide—hematologic cancer	9.79e-05	0.000412	CcSEcCtD
Thiabendazole—Dizziness—Carmustine—hematologic cancer	9.78e-05	0.000411	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ARNTL—hematologic cancer	9.74e-05	0.00329	CbGpPWpGaD
Thiabendazole—Rash—Thalidomide—hematologic cancer	9.71e-05	0.000408	CcSEcCtD
Thiabendazole—Dermatitis—Thalidomide—hematologic cancer	9.7e-05	0.000408	CcSEcCtD
Thiabendazole—Dizziness—Alitretinoin—hematologic cancer	9.69e-05	0.000407	CcSEcCtD
Thiabendazole—Diarrhoea—Vincristine—hematologic cancer	9.66e-05	0.000406	CcSEcCtD
Thiabendazole—Headache—Thalidomide—hematologic cancer	9.65e-05	0.000406	CcSEcCtD
Thiabendazole—Asthenia—Gemcitabine—hematologic cancer	9.61e-05	0.000404	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—hematologic cancer	9.59e-05	0.000403	CcSEcCtD
Thiabendazole—Dizziness—Ifosfamide—hematologic cancer	9.58e-05	0.000403	CcSEcCtD
Thiabendazole—Pruritus—Gemcitabine—hematologic cancer	9.48e-05	0.000398	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—hematologic cancer	9.47e-05	0.000398	CcSEcCtD
Thiabendazole—Nausea—Thiotepa—hematologic cancer	9.46e-05	0.000398	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—hematologic cancer	9.43e-05	0.000396	CcSEcCtD
Thiabendazole—Anaphylactic shock—Betamethasone—hematologic cancer	9.41e-05	0.000396	CcSEcCtD
Thiabendazole—Anaphylactic shock—Dexamethasone—hematologic cancer	9.41e-05	0.000396	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—hematologic cancer	9.41e-05	0.000396	CcSEcCtD
Thiabendazole—Diarrhoea—Irinotecan—hematologic cancer	9.41e-05	0.000395	CcSEcCtD
Thiabendazole—Diarrhoea—Mitoxantrone—hematologic cancer	9.41e-05	0.000395	CcSEcCtD
Thiabendazole—Vomiting—Carmustine—hematologic cancer	9.41e-05	0.000395	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—UGT1A1—hematologic cancer	9.36e-05	0.00316	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Etoposide—hematologic cancer	9.35e-05	0.000393	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR2—hematologic cancer	9.35e-05	0.00315	CbGpPWpGaD
Thiabendazole—Dizziness—Vincristine—hematologic cancer	9.34e-05	0.000392	CcSEcCtD
Thiabendazole—Rash—Carmustine—hematologic cancer	9.33e-05	0.000392	CcSEcCtD
Thiabendazole—Dermatitis—Carmustine—hematologic cancer	9.32e-05	0.000392	CcSEcCtD
Thiabendazole—Vomiting—Alitretinoin—hematologic cancer	9.32e-05	0.000392	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—hematologic cancer	9.3e-05	0.000391	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisolone—hematologic cancer	9.3e-05	0.000391	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—hematologic cancer	9.29e-05	0.000391	CcSEcCtD
Thiabendazole—Headache—Carmustine—hematologic cancer	9.27e-05	0.00039	CcSEcCtD
Thiabendazole—Rash—Alitretinoin—hematologic cancer	9.24e-05	0.000388	CcSEcCtD
Thiabendazole—Dermatitis—Alitretinoin—hematologic cancer	9.23e-05	0.000388	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	9.22e-05	0.000388	CcSEcCtD
Thiabendazole—Vomiting—Ifosfamide—hematologic cancer	9.21e-05	0.000387	CcSEcCtD
Thiabendazole—Hypersensitivity—Cisplatin—hematologic cancer	9.2e-05	0.000387	CcSEcCtD
Thiabendazole—Headache—Alitretinoin—hematologic cancer	9.18e-05	0.000386	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—hematologic cancer	9.18e-05	0.000386	CcSEcCtD
Thiabendazole—Diarrhoea—Gemcitabine—hematologic cancer	9.17e-05	0.000385	CcSEcCtD
Thiabendazole—Nausea—Thalidomide—hematologic cancer	9.15e-05	0.000385	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GSTO1—hematologic cancer	9.14e-05	0.00308	CbGpPWpGaD
Thiabendazole—Dyspepsia—Triamcinolone—hematologic cancer	9.13e-05	0.000384	CcSEcCtD
Thiabendazole—Rash—Ifosfamide—hematologic cancer	9.13e-05	0.000384	CcSEcCtD
Thiabendazole—Dermatitis—Ifosfamide—hematologic cancer	9.12e-05	0.000383	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—hematologic cancer	9.12e-05	0.000383	CcSEcCtD
Thiabendazole—Dizziness—Irinotecan—hematologic cancer	9.09e-05	0.000382	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—hematologic cancer	9.07e-05	0.000381	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—hematologic cancer	9.04e-05	0.00038	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—SLC35B2—hematologic cancer	9.04e-05	0.00305	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTO1—hematologic cancer	9.01e-05	0.00304	CbGpPWpGaD
Thiabendazole—Tinnitus—Methotrexate—hematologic cancer	8.99e-05	0.000378	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—hematologic cancer	8.98e-05	0.000377	CcSEcCtD
Thiabendazole—Vomiting—Vincristine—hematologic cancer	8.98e-05	0.000377	CcSEcCtD
Thiabendazole—Anorexia—Dexamethasone—hematologic cancer	8.97e-05	0.000377	CcSEcCtD
Thiabendazole—Anorexia—Betamethasone—hematologic cancer	8.97e-05	0.000377	CcSEcCtD
Thiabendazole—Asthenia—Cisplatin—hematologic cancer	8.96e-05	0.000377	CcSEcCtD
Thiabendazole—Fatigue—Triamcinolone—hematologic cancer	8.95e-05	0.000376	CcSEcCtD
Thiabendazole—CYP1A2—Metapathway biotransformation—EPHX1—hematologic cancer	8.92e-05	0.00301	CbGpPWpGaD
Thiabendazole—Rash—Vincristine—hematologic cancer	8.9e-05	0.000374	CcSEcCtD
Thiabendazole—Dermatitis—Vincristine—hematologic cancer	8.9e-05	0.000374	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	8.89e-05	0.003	CbGpPWpGaD
Thiabendazole—Haematuria—Doxorubicin—hematologic cancer	8.87e-05	0.000373	CcSEcCtD
Thiabendazole—Headache—Vincristine—hematologic cancer	8.85e-05	0.000372	CcSEcCtD
Thiabendazole—Hypotension—Dexamethasone—hematologic cancer	8.8e-05	0.00037	CcSEcCtD
Thiabendazole—Hypotension—Betamethasone—hematologic cancer	8.8e-05	0.00037	CcSEcCtD
Thiabendazole—Nausea—Carmustine—hematologic cancer	8.79e-05	0.000369	CcSEcCtD
Thiabendazole—Vomiting—Mitoxantrone—hematologic cancer	8.74e-05	0.000368	CcSEcCtD
Thiabendazole—Vomiting—Irinotecan—hematologic cancer	8.74e-05	0.000368	CcSEcCtD
Thiabendazole—Nausea—Alitretinoin—hematologic cancer	8.7e-05	0.000366	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—hematologic cancer	8.7e-05	0.000366	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—hematologic cancer	8.7e-05	0.000366	CcSEcCtD
Thiabendazole—Rash—Irinotecan—hematologic cancer	8.67e-05	0.000364	CcSEcCtD
Thiabendazole—Rash—Mitoxantrone—hematologic cancer	8.67e-05	0.000364	CcSEcCtD
Thiabendazole—Dermatitis—Mitoxantrone—hematologic cancer	8.66e-05	0.000364	CcSEcCtD
Thiabendazole—Dermatitis—Irinotecan—hematologic cancer	8.66e-05	0.000364	CcSEcCtD
Thiabendazole—Chills—Methotrexate—hematologic cancer	8.65e-05	0.000364	CcSEcCtD
Thiabendazole—Headache—Irinotecan—hematologic cancer	8.62e-05	0.000362	CcSEcCtD
Thiabendazole—Headache—Mitoxantrone—hematologic cancer	8.62e-05	0.000362	CcSEcCtD
Thiabendazole—Nausea—Ifosfamide—hematologic cancer	8.6e-05	0.000362	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—UGT1A1—hematologic cancer	8.59e-05	0.0029	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Triamcinolone—hematologic cancer	8.55e-05	0.000359	CcSEcCtD
Thiabendazole—Diarrhoea—Cisplatin—hematologic cancer	8.54e-05	0.000359	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—hematologic cancer	8.53e-05	0.000359	CcSEcCtD
Thiabendazole—Vomiting—Gemcitabine—hematologic cancer	8.52e-05	0.000358	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	8.52e-05	0.00287	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—UGT1A1—hematologic cancer	8.47e-05	0.00286	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	8.45e-05	0.00285	CbGpPWpGaD
Thiabendazole—Rash—Gemcitabine—hematologic cancer	8.45e-05	0.000355	CcSEcCtD
Thiabendazole—Dermatitis—Gemcitabine—hematologic cancer	8.44e-05	0.000355	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—hematologic cancer	8.43e-05	0.000354	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—hematologic cancer	8.42e-05	0.000354	CcSEcCtD
Thiabendazole—Headache—Gemcitabine—hematologic cancer	8.39e-05	0.000353	CcSEcCtD
Thiabendazole—Nausea—Vincristine—hematologic cancer	8.39e-05	0.000353	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—hematologic cancer	8.38e-05	0.000352	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisolone—hematologic cancer	8.31e-05	0.000349	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	8.31e-05	0.0028	CbGpPWpGaD
Thiabendazole—Hypoaesthesia—Doxorubicin—hematologic cancer	8.31e-05	0.000349	CcSEcCtD
Thiabendazole—Dyspepsia—Betamethasone—hematologic cancer	8.29e-05	0.000348	CcSEcCtD
Thiabendazole—Dyspepsia—Dexamethasone—hematologic cancer	8.29e-05	0.000348	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—hematologic cancer	8.21e-05	0.000345	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—hematologic cancer	8.2e-05	0.000345	CcSEcCtD
Thiabendazole—Decreased appetite—Betamethasone—hematologic cancer	8.18e-05	0.000344	CcSEcCtD
Thiabendazole—Decreased appetite—Dexamethasone—hematologic cancer	8.18e-05	0.000344	CcSEcCtD
Thiabendazole—Nausea—Irinotecan—hematologic cancer	8.17e-05	0.000343	CcSEcCtD
Thiabendazole—Nausea—Mitoxantrone—hematologic cancer	8.17e-05	0.000343	CcSEcCtD
Thiabendazole—CYP1A2—Phase II conjugation—MTR—hematologic cancer	8.12e-05	0.00274	CbGpPWpGaD
Thiabendazole—Fatigue—Dexamethasone—hematologic cancer	8.12e-05	0.000341	CcSEcCtD
Thiabendazole—Fatigue—Betamethasone—hematologic cancer	8.12e-05	0.000341	CcSEcCtD
Thiabendazole—Chills—Epirubicin—hematologic cancer	8.1e-05	0.00034	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—hematologic cancer	8.09e-05	0.00034	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—hematologic cancer	8.06e-05	0.00272	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	8.05e-05	0.00272	CbGpPWpGaD
Thiabendazole—Visual impairment—Doxorubicin—hematologic cancer	8.05e-05	0.000338	CcSEcCtD
Thiabendazole—Nausea—Gemcitabine—hematologic cancer	7.96e-05	0.000334	CcSEcCtD
Thiabendazole—Vomiting—Cisplatin—hematologic cancer	7.94e-05	0.000334	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—hematologic cancer	7.91e-05	0.000333	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—hematologic cancer	7.9e-05	0.000332	CcSEcCtD
Thiabendazole—Rash—Cisplatin—hematologic cancer	7.87e-05	0.000331	CcSEcCtD
Thiabendazole—Dermatitis—Cisplatin—hematologic cancer	7.87e-05	0.000331	CcSEcCtD
Thiabendazole—Diarrhoea—Etoposide—hematologic cancer	7.83e-05	0.000329	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—hematologic cancer	7.82e-05	0.000328	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—hematologic cancer	7.79e-05	0.000327	CcSEcCtD
Thiabendazole—Feeling abnormal—Dexamethasone—hematologic cancer	7.76e-05	0.000326	CcSEcCtD
Thiabendazole—Feeling abnormal—Betamethasone—hematologic cancer	7.76e-05	0.000326	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—hematologic cancer	7.75e-05	0.000326	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	7.73e-05	0.00261	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	7.72e-05	0.0026	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Betamethasone—hematologic cancer	7.7e-05	0.000324	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.7e-05	0.000324	CcSEcCtD
Thiabendazole—Hypersensitivity—Triamcinolone—hematologic cancer	7.64e-05	0.000321	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	7.62e-05	0.00257	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MDM2—hematologic cancer	7.58e-05	0.00256	CbGpPWpGaD
Thiabendazole—Dizziness—Etoposide—hematologic cancer	7.56e-05	0.000318	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—hematologic cancer	7.52e-05	0.000316	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—hematologic cancer	7.49e-05	0.000315	CcSEcCtD
Thiabendazole—Dizziness—Prednisolone—hematologic cancer	7.46e-05	0.000314	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—MTR—hematologic cancer	7.45e-05	0.00251	CbGpPWpGaD
Thiabendazole—Asthenia—Triamcinolone—hematologic cancer	7.44e-05	0.000313	CcSEcCtD
Thiabendazole—Abdominal pain—Betamethasone—hematologic cancer	7.44e-05	0.000313	CcSEcCtD
Thiabendazole—Abdominal pain—Dexamethasone—hematologic cancer	7.44e-05	0.000313	CcSEcCtD
Thiabendazole—Nausea—Cisplatin—hematologic cancer	7.42e-05	0.000312	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—hematologic cancer	7.4e-05	0.000311	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—hematologic cancer	7.38e-05	0.00249	CbGpPWpGaD
Thiabendazole—Pruritus—Triamcinolone—hematologic cancer	7.34e-05	0.000309	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—hematologic cancer	7.27e-05	0.000306	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—hematologic cancer	7.27e-05	0.000306	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—hematologic cancer	7.22e-05	0.000303	CcSEcCtD
Thiabendazole—Rash—Etoposide—hematologic cancer	7.21e-05	0.000303	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—hematologic cancer	7.21e-05	0.000303	CcSEcCtD
Thiabendazole—Headache—Etoposide—hematologic cancer	7.17e-05	0.000301	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—hematologic cancer	7.13e-05	0.0003	CcSEcCtD
Thiabendazole—Rash—Prednisolone—hematologic cancer	7.11e-05	0.000299	CcSEcCtD
Thiabendazole—Dermatitis—Prednisolone—hematologic cancer	7.11e-05	0.000299	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GSTT1—hematologic cancer	7.08e-05	0.00239	CbGpPWpGaD
Thiabendazole—Fatigue—Prednisone—hematologic cancer	7.07e-05	0.000297	CcSEcCtD
Thiabendazole—Headache—Prednisolone—hematologic cancer	7.07e-05	0.000297	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—hematologic cancer	7.03e-05	0.000296	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	6.92e-05	0.00233	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	6.92e-05	0.00233	CbGpPWpGaD
Thiabendazole—Confusional state—Methotrexate—hematologic cancer	6.91e-05	0.00029	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	6.9e-05	0.00233	CbGpPWpGaD
Thiabendazole—Dizziness—Triamcinolone—hematologic cancer	6.86e-05	0.000288	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—hematologic cancer	6.85e-05	0.000288	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—hematologic cancer	6.85e-05	0.000288	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—hematologic cancer	6.81e-05	0.000286	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	6.8e-05	0.00229	CbGpPWpGaD
Thiabendazole—Nausea—Etoposide—hematologic cancer	6.79e-05	0.000286	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	6.77e-05	0.00228	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Prednisone—hematologic cancer	6.76e-05	0.000284	CcSEcCtD
Thiabendazole—Asthenia—Dexamethasone—hematologic cancer	6.75e-05	0.000284	CcSEcCtD
Thiabendazole—Asthenia—Betamethasone—hematologic cancer	6.75e-05	0.000284	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—hematologic cancer	6.7e-05	0.000282	CcSEcCtD
Thiabendazole—Nausea—Prednisolone—hematologic cancer	6.7e-05	0.000282	CcSEcCtD
Thiabendazole—Pruritus—Betamethasone—hematologic cancer	6.66e-05	0.00028	CcSEcCtD
Thiabendazole—Pruritus—Dexamethasone—hematologic cancer	6.66e-05	0.00028	CcSEcCtD
Thiabendazole—Vomiting—Triamcinolone—hematologic cancer	6.6e-05	0.000277	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	6.59e-05	0.00222	CbGpPWpGaD
Thiabendazole—Rash—Triamcinolone—hematologic cancer	6.54e-05	0.000275	CcSEcCtD
Thiabendazole—Dermatitis—Triamcinolone—hematologic cancer	6.54e-05	0.000275	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—hematologic cancer	6.53e-05	0.000275	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—hematologic cancer	6.51e-05	0.000274	CcSEcCtD
Thiabendazole—Headache—Triamcinolone—hematologic cancer	6.5e-05	0.000273	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	6.49e-05	0.00219	CbGpPWpGaD
Thiabendazole—Abdominal pain—Prednisone—hematologic cancer	6.48e-05	0.000272	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—hematologic cancer	6.47e-05	0.000272	CcSEcCtD
Thiabendazole—CYP1A1—PPARA activates gene expression—NCOR1—hematologic cancer	6.45e-05	0.00218	CbGpPWpGaD
Thiabendazole—Diarrhoea—Betamethasone—hematologic cancer	6.44e-05	0.000271	CcSEcCtD
Thiabendazole—Diarrhoea—Dexamethasone—hematologic cancer	6.44e-05	0.000271	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—hematologic cancer	6.41e-05	0.00027	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—hematologic cancer	6.4e-05	0.000269	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	6.39e-05	0.00215	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—hematologic cancer	6.32e-05	0.00213	CbGpPWpGaD
Thiabendazole—Convulsion—Doxorubicin—hematologic cancer	6.3e-05	0.000265	CcSEcCtD
Thiabendazole—Dizziness—Betamethasone—hematologic cancer	6.23e-05	0.000262	CcSEcCtD
Thiabendazole—Dizziness—Dexamethasone—hematologic cancer	6.23e-05	0.000262	CcSEcCtD
Thiabendazole—Nausea—Triamcinolone—hematologic cancer	6.16e-05	0.000259	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—hematologic cancer	6.11e-05	0.000257	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—hematologic cancer	6.09e-05	0.000256	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	6.08e-05	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	6.08e-05	0.00205	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Prednisone—hematologic cancer	6.04e-05	0.000254	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—hematologic cancer	6.03e-05	0.000254	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—hematologic cancer	5.99e-05	0.000252	CcSEcCtD
Thiabendazole—Vomiting—Betamethasone—hematologic cancer	5.99e-05	0.000252	CcSEcCtD
Thiabendazole—Vomiting—Dexamethasone—hematologic cancer	5.99e-05	0.000252	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—hematologic cancer	5.98e-05	0.000251	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—hematologic cancer	5.96e-05	0.00025	CcSEcCtD
Thiabendazole—Rash—Dexamethasone—hematologic cancer	5.94e-05	0.000249	CcSEcCtD
Thiabendazole—Rash—Betamethasone—hematologic cancer	5.94e-05	0.000249	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—hematologic cancer	5.93e-05	0.000249	CcSEcCtD
Thiabendazole—Dermatitis—Dexamethasone—hematologic cancer	5.93e-05	0.000249	CcSEcCtD
Thiabendazole—Dermatitis—Betamethasone—hematologic cancer	5.93e-05	0.000249	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	5.91e-05	0.00199	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	5.91e-05	0.00199	CbGpPWpGaD
Thiabendazole—Fatigue—Methotrexate—hematologic cancer	5.91e-05	0.000248	CcSEcCtD
Thiabendazole—Headache—Betamethasone—hematologic cancer	5.9e-05	0.000248	CcSEcCtD
Thiabendazole—Headache—Dexamethasone—hematologic cancer	5.9e-05	0.000248	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—hematologic cancer	5.88e-05	0.000247	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	5.83e-05	0.00196	CbGpPWpGaD
Thiabendazole—Pruritus—Prednisone—hematologic cancer	5.8e-05	0.000244	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	5.76e-05	0.00194	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	5.75e-05	0.00194	CbGpPWpGaD
Thiabendazole—Somnolence—Epirubicin—hematologic cancer	5.7e-05	0.00024	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	5.69e-05	0.00192	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	5.67e-05	0.00191	CbGpPWpGaD
Thiabendazole—Anorexia—Doxorubicin—hematologic cancer	5.66e-05	0.000238	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—hematologic cancer	5.65e-05	0.000237	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—hematologic cancer	5.64e-05	0.000237	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—hematologic cancer	5.61e-05	0.000236	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—hematologic cancer	5.6e-05	0.000235	CcSEcCtD
Thiabendazole—Nausea—Betamethasone—hematologic cancer	5.59e-05	0.000235	CcSEcCtD
Thiabendazole—Nausea—Dexamethasone—hematologic cancer	5.59e-05	0.000235	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—hematologic cancer	5.57e-05	0.000234	CcSEcCtD
Thiabendazole—Hypotension—Doxorubicin—hematologic cancer	5.54e-05	0.000233	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—hematologic cancer	5.53e-05	0.000232	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	5.48e-05	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	5.44e-05	0.00184	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	5.43e-05	0.00183	CbGpPWpGaD
Thiabendazole—Dizziness—Prednisone—hematologic cancer	5.42e-05	0.000228	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—hematologic cancer	5.42e-05	0.000228	CcSEcCtD
Thiabendazole—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	5.4e-05	0.00182	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	5.39e-05	0.00182	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	5.35e-05	0.00181	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	5.3e-05	0.00179	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Epirubicin—hematologic cancer	5.28e-05	0.000222	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	5.28e-05	0.00178	CbGpPWpGaD
Thiabendazole—Somnolence—Doxorubicin—hematologic cancer	5.27e-05	0.000222	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—hematologic cancer	5.24e-05	0.00022	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—hematologic cancer	5.22e-05	0.00022	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—hematologic cancer	5.21e-05	0.000219	CcSEcCtD
Thiabendazole—Rash—Prednisone—hematologic cancer	5.17e-05	0.000217	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—hematologic cancer	5.16e-05	0.000217	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—hematologic cancer	5.16e-05	0.000217	CcSEcCtD
Thiabendazole—Headache—Prednisone—hematologic cancer	5.14e-05	0.000216	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—hematologic cancer	5.12e-05	0.000215	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—hematologic cancer	5.07e-05	0.000213	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—hematologic cancer	5.05e-05	0.000212	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	4.93e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	4.93e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	4.93e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	4.92e-05	0.00166	CbGpPWpGaD
Thiabendazole—Asthenia—Methotrexate—hematologic cancer	4.92e-05	0.000207	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GSTP1—hematologic cancer	4.91e-05	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	4.89e-05	0.00165	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Doxorubicin—hematologic cancer	4.89e-05	0.000205	CcSEcCtD
Thiabendazole—Nausea—Prednisone—hematologic cancer	4.87e-05	0.000205	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	4.86e-05	0.00164	CbGpPWpGaD
Thiabendazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.85e-05	0.000204	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—hematologic cancer	4.85e-05	0.000204	CcSEcCtD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTP1—hematologic cancer	4.84e-05	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	4.83e-05	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MTR—hematologic cancer	4.75e-05	0.0016	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Epirubicin—hematologic cancer	4.72e-05	0.000199	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—hematologic cancer	4.69e-05	0.000197	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—hematologic cancer	4.69e-05	0.000197	CcSEcCtD
Thiabendazole—Asthenia—Epirubicin—hematologic cancer	4.6e-05	0.000193	CcSEcCtD
Thiabendazole—Pruritus—Epirubicin—hematologic cancer	4.54e-05	0.000191	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—hematologic cancer	4.53e-05	0.00019	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	4.52e-05	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—hematologic cancer	4.51e-05	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—hematologic cancer	4.45e-05	0.0015	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CREBBP—hematologic cancer	4.44e-05	0.0015	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	4.44e-05	0.0015	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	4.41e-05	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	4.41e-05	0.00149	CbGpPWpGaD
Thiabendazole—Diarrhoea—Epirubicin—hematologic cancer	4.39e-05	0.000184	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—hematologic cancer	4.37e-05	0.000184	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—hematologic cancer	4.36e-05	0.000183	CcSEcCtD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—hematologic cancer	4.35e-05	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—hematologic cancer	4.35e-05	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	4.33e-05	0.00146	CbGpPWpGaD
Thiabendazole—Rash—Methotrexate—hematologic cancer	4.32e-05	0.000182	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	4.32e-05	0.00146	CbGpPWpGaD
Thiabendazole—Dermatitis—Methotrexate—hematologic cancer	4.32e-05	0.000181	CcSEcCtD
Thiabendazole—Headache—Methotrexate—hematologic cancer	4.29e-05	0.00018	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—hematologic cancer	4.26e-05	0.000179	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—hematologic cancer	4.24e-05	0.000178	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	4.2e-05	0.00142	CbGpPWpGaD
Thiabendazole—Pruritus—Doxorubicin—hematologic cancer	4.2e-05	0.000176	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	4.16e-05	0.0014	CbGpPWpGaD
Thiabendazole—Vomiting—Epirubicin—hematologic cancer	4.08e-05	0.000171	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	4.07e-05	0.00137	CbGpPWpGaD
Thiabendazole—Nausea—Methotrexate—hematologic cancer	4.07e-05	0.000171	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—hematologic cancer	4.06e-05	0.000171	CcSEcCtD
Thiabendazole—Rash—Epirubicin—hematologic cancer	4.04e-05	0.00017	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—hematologic cancer	4.04e-05	0.00017	CcSEcCtD
Thiabendazole—Headache—Epirubicin—hematologic cancer	4.02e-05	0.000169	CcSEcCtD
Thiabendazole—Dizziness—Doxorubicin—hematologic cancer	3.92e-05	0.000165	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	3.88e-05	0.00131	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	3.88e-05	0.00131	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	3.88e-05	0.00131	CbGpPWpGaD
Thiabendazole—Nausea—Epirubicin—hematologic cancer	3.81e-05	0.00016	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—hematologic cancer	3.77e-05	0.000159	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	3.77e-05	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	3.77e-05	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GMPS—hematologic cancer	3.76e-05	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PHYH—hematologic cancer	3.76e-05	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FTCD—hematologic cancer	3.76e-05	0.00127	CbGpPWpGaD
Thiabendazole—Rash—Doxorubicin—hematologic cancer	3.74e-05	0.000157	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—hematologic cancer	3.74e-05	0.000157	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	3.72e-05	0.00126	CbGpPWpGaD
Thiabendazole—Headache—Doxorubicin—hematologic cancer	3.72e-05	0.000156	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	3.67e-05	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	3.63e-05	0.00122	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	3.55e-05	0.0012	CbGpPWpGaD
Thiabendazole—Nausea—Doxorubicin—hematologic cancer	3.52e-05	0.000148	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	3.51e-05	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.47e-05	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SMPD3—hematologic cancer	3.44e-05	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	3.43e-05	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	3.38e-05	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	3.37e-05	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.21e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	3.15e-05	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	3.15e-05	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	3.13e-05	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.13e-05	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	3.12e-05	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	3.09e-05	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—EP300—hematologic cancer	3.03e-05	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—B3GAT1—hematologic cancer	3.01e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ASNS—hematologic cancer	3.01e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DCK—hematologic cancer	3.01e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	3e-05	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—hematologic cancer	2.96e-05	0.000999	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.94e-05	0.000992	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	2.88e-05	0.00097	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HDC—hematologic cancer	2.85e-05	0.000962	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.84e-05	0.000957	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.83e-05	0.000954	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.66e-05	0.000897	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.65e-05	0.000894	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CDA—hematologic cancer	2.61e-05	0.00088	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PC—hematologic cancer	2.51e-05	0.000847	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.47e-05	0.000834	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GBA—hematologic cancer	2.42e-05	0.000818	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC35B2—hematologic cancer	2.42e-05	0.000818	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FTCD—hematologic cancer	2.4e-05	0.000809	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PHYH—hematologic cancer	2.4e-05	0.000809	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GMPS—hematologic cancer	2.4e-05	0.000809	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.38e-05	0.000801	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.26e-05	0.000763	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.24e-05	0.000755	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTAP—hematologic cancer	2.22e-05	0.000748	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SMPD3—hematologic cancer	2.19e-05	0.00074	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.19e-05	0.000738	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.05e-05	0.00069	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	2.04e-05	0.000688	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.99e-05	0.000672	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FHL2—hematologic cancer	1.98e-05	0.000667	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AGRN—hematologic cancer	1.94e-05	0.000654	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.92e-05	0.000647	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ASNS—hematologic cancer	1.92e-05	0.000647	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DCK—hematologic cancer	1.92e-05	0.000647	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.87e-05	0.000632	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH2—hematologic cancer	1.84e-05	0.00062	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMMR—hematologic cancer	1.84e-05	0.00062	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HDC—hematologic cancer	1.82e-05	0.000613	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.73e-05	0.000584	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ARNTL—hematologic cancer	1.73e-05	0.000583	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.7e-05	0.000572	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA9—hematologic cancer	1.68e-05	0.000567	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACP5—hematologic cancer	1.68e-05	0.000567	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CDA—hematologic cancer	1.66e-05	0.000561	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOR2—hematologic cancer	1.66e-05	0.000559	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PC—hematologic cancer	1.6e-05	0.00054	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH1—hematologic cancer	1.58e-05	0.000533	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TXN—hematologic cancer	1.56e-05	0.000527	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCC3—hematologic cancer	1.56e-05	0.000527	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTO1—hematologic cancer	1.56e-05	0.000527	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GBA—hematologic cancer	1.55e-05	0.000521	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.55e-05	0.000521	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SPHK1—hematologic cancer	1.53e-05	0.000516	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UGT1A1—hematologic cancer	1.47e-05	0.000495	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CRABP1—hematologic cancer	1.43e-05	0.000482	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC22A1—hematologic cancer	1.43e-05	0.000482	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTAP—hematologic cancer	1.41e-05	0.000477	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX5—hematologic cancer	1.39e-05	0.00047	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NUP98—hematologic cancer	1.35e-05	0.000455	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADCY7—hematologic cancer	1.31e-05	0.000442	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA3—hematologic cancer	1.31e-05	0.000442	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NUP214—hematologic cancer	1.3e-05	0.000439	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.29e-05	0.000434	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG2—hematologic cancer	1.27e-05	0.00043	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTR—hematologic cancer	1.27e-05	0.00043	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FHL2—hematologic cancer	1.26e-05	0.000425	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO2—hematologic cancer	1.25e-05	0.000421	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AGRN—hematologic cancer	1.24e-05	0.000417	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—hematologic cancer	1.21e-05	0.000409	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.19e-05	0.000402	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SDC1—hematologic cancer	1.18e-05	0.000399	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH2—hematologic cancer	1.17e-05	0.000395	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMMR—hematologic cancer	1.17e-05	0.000395	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.13e-05	0.000381	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.12e-05	0.000377	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.1e-05	0.000373	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.1e-05	0.000372	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA9—hematologic cancer	1.07e-05	0.000361	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACP5—hematologic cancer	1.07e-05	0.000361	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.07e-05	0.00036	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.06e-05	0.000357	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH1—hematologic cancer	1.01e-05	0.00034	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CD44—hematologic cancer	1.01e-05	0.00034	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NQO1—hematologic cancer	1.01e-05	0.00034	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTO1—hematologic cancer	9.96e-06	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCC3—hematologic cancer	9.96e-06	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TXN—hematologic cancer	9.96e-06	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.86e-06	0.000333	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SPHK1—hematologic cancer	9.75e-06	0.000329	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYCS—hematologic cancer	9.53e-06	0.000321	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	9.47e-06	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UGT1A1—hematologic cancer	9.37e-06	0.000316	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC22A1—hematologic cancer	9.11e-06	0.000307	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CRABP1—hematologic cancer	9.11e-06	0.000307	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX5—hematologic cancer	8.88e-06	0.000299	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NUP98—hematologic cancer	8.6e-06	0.00029	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.52e-06	0.000287	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—hematologic cancer	8.4e-06	0.000283	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADCY7—hematologic cancer	8.35e-06	0.000282	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA3—hematologic cancer	8.35e-06	0.000282	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NUP214—hematologic cancer	8.29e-06	0.00028	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.2e-06	0.000277	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.13e-06	0.000274	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG2—hematologic cancer	8.12e-06	0.000274	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTR—hematologic cancer	8.12e-06	0.000274	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO2—hematologic cancer	7.96e-06	0.000269	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—hematologic cancer	7.95e-06	0.000268	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—hematologic cancer	7.73e-06	0.000261	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—hematologic cancer	7.72e-06	0.00026	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOR1—hematologic cancer	7.72e-06	0.00026	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.61e-06	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SDC1—hematologic cancer	7.55e-06	0.000255	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.21e-06	0.000243	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.12e-06	0.00024	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—hematologic cancer	6.82e-06	0.00023	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.81e-06	0.00023	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CD44—hematologic cancer	6.42e-06	0.000217	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NQO1—hematologic cancer	6.42e-06	0.000217	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.29e-06	0.000212	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYCS—hematologic cancer	6.08e-06	0.000205	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.04e-06	0.000204	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.01e-06	0.000203	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—hematologic cancer	5.73e-06	0.000193	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.43e-06	0.000183	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.35e-06	0.000181	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CREBBP—hematologic cancer	5.31e-06	0.000179	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.18e-06	0.000175	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.07e-06	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CD—hematologic cancer	5.04e-06	0.00017	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—hematologic cancer	4.97e-06	0.000168	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.92e-06	0.000166	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.92e-06	0.000166	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3R1—hematologic cancer	4.76e-06	0.00016	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CB—hematologic cancer	4.39e-06	0.000148	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.35e-06	0.000147	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.83e-06	0.000129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTEN—hematologic cancer	3.79e-06	0.000128	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.65e-06	0.000123	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EP300—hematologic cancer	3.62e-06	0.000122	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.39e-06	0.000114	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.21e-06	0.000108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—hematologic cancer	3.17e-06	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.03e-06	0.000102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.8e-06	9.44e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—hematologic cancer	2.68e-06	9.03e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTEN—hematologic cancer	2.42e-06	8.16e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EP300—hematologic cancer	2.31e-06	7.78e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—hematologic cancer	2.19e-06	7.37e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.71e-06	5.76e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—hematologic cancer	1.39e-06	4.7e-05	CbGpPWpGaD
